Expert Review of Anticancer Therapy

Title Publication Date Language Citations
Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review2017/02/24English104
Oral and Oropharyngeal squamous cell carcinoma: prognostic and predictive parameters in the etiopathogenetic route2019/01/15English104
Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma2004/06/01English98
MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century2009/08/01English98
Present and potential future issues in glioblastoma treatment2006/05/01English96
MYC in breast tumor progression2008/10/01English95
New treatment strategies for malignant gliomas2006/07/01English95
Optimizing treatment in recurrent epithelial ovarian cancer2017/11/06English94
ROS1 as a ‘druggable’ receptor tyrosine kinase: lessons learned from inhibiting the ALK pathway2012/04/01English93
Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis2004/02/01English92
Molecular mechanisms of temozolomide resistance in glioblastoma multiforme2012/05/01English92
The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy2016/06/03English90
Nivolumab for the treatment of hepatocellular carcinoma2018/10/22English89
Cancer immunotherapy: activating innate and adaptive immunity through CD40 agonists2016/12/14English89
Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1–derived oncolytic immunotherapy2015/12/02English88
Current epidemiological trends and surveillance issues in brain tumors2001/10/01English87
Lapatinib in the treatment of breast cancer2007/09/01English86
Bexarotene: a clinical review2004/04/01English85
Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial2009/06/01English85
Hydroxyurea: a key player in cancer chemotherapy2012/01/01English84
Biological role of α-fetoprotein in cancer: prospects for anticancer therapy2002/12/01English83
Antibody-directed enzyme prodrug therapy (ADEPT) for cancer2006/10/01English82
Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma2009/08/01English82
Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges2007/10/01English82
Epidemiology and treatment patterns of epithelial ovarian cancer2017/03/22English82
Genome-wide association studies: how predictable is a person’s cancer risk?2009/04/01English82
Molecular mechanisms of cisplatin resistance in bladder cancer2012/02/01English82
Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab2009/04/01English79
Immunotherapy and targeted therapy for cervical cancer: an update2015/12/07English79
Histone deacetylase inhibitors in lymphoma and solid malignancies2008/03/01English78